Form EFFECT Aegerion Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 10, 2016 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silver Spruce Resources, Inc. Purchases 100% Interest in Pino de Plata Claims in Mexico
- Jones Soda Announces Limited-Edition Crayola Collaboration as Part of 30th Anniversary "Dirty 30" Celebration
- Azimut Drills High-Grade Lithium Pegmatites at Wabamisk East
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
